Products

Clinical Stage Portfolio With Multiple Shots on Goal Resources Prioritized For Bertilimumab Phase II BP and UC Trials

Immune Pharmaceuticals Preclinical Phase 1 Phase 2 Phase 3
Bullous Pemphigoid PreclinicalPhase 1Phase 2Phase 3
IBD (Ulcerative Colitis) PreclinicalPhase 1Phase 2Phase 3
Atopic Dermatitis / Psoriasis PreclinicalPhase 1Phase 2Phase 3
NASH PreclinicalPhase 1Phase 2Phase 3

LEARN MORE ABOUT Immune Pharmaceuticals

Cytovia Immuno Oncology Preclinical Phase 1 Phase 2 Phase 3
Ceplene* Approved in EU PreclinicalPhase 1Phase 2Phase 3
Crolibulin/Azixa PreclinicalPhase 1Phase 2Phase 3
Nanomabs PreclinicalPhase 1Phase 2Phase 3
Bispecific Antibodies PreclinicalPhase 1Phase 2Phase 3

LEARN MORE ABOUT Cytovia Immuno Oncology

Maxim Pharmaceuticals Preclinical Phase 1 Phase 2 Phase 3
AmiKet PreclinicalPhase 1Phase 2Phase 3

LEARN MORE ABOUT Maxim Pharmaceuticals